This inventor holds 31 USPTO granted patents and 1 published patent application and 1 EPO patent, primarily in Kinase Inhibitors. Top assignees: Janssen Pharmaceutica Nv, Ortho-Mcneil Pharmaceutical Corp., Millennium Pharmaceuticals Limited. Active years: 2002-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Landsale, PA (US) (2009)
- Lansdale, PA (US) (2002 - 2014)
Company Filing History:
17 out of 2,100 
12 out of 363 
2 out of 854 
Years Active: 2002-2014
Areas of Expertise:
Title: Han-Cheng Zhang: Innovating in Pharmaceutical Science
Introduction
Han-Cheng Zhang, based in Lansdale, PA, is an accomplished inventor with an impressive portfolio of 31 patents. His innovative contributions primarily focus on pharmaceutical chemistry, emphasizing the development of therapeutic agents.
Latest Patents
Among his latest inventions, Zhang has developed novel 2,3-dihydro-1H-isoindol-1-imine derivatives that serve as thrombin PAR-1 receptor antagonists. This invention aims to provide new pharmacological tools for treating disorders modulated by these receptors. Another significant patent involves spiropiperidines for use as tryptase inhibitors, showcasing his ongoing commitment to addressing complex medical challenges through innovative chemical compounds.
Career Highlights
Zhang has worked with notable companies in the pharmaceutical sector, including Janssen Pharmaceutica and Ortho-McNeil Pharmaceutical Corporation. His work in these organizations has furthered the development of important pharmaceutical technologies and allowed him to push the boundaries of current therapeutic options.
Collaborations
Throughout his career, Han-Cheng Zhang has collaborated with distinguished colleagues such as Bruce E Maryanoff and Hong Ye. These partnerships highlight the collaborative nature of science and reflect the value of teamwork in achieving groundbreaking innovations.
Conclusion
Han-Cheng Zhang's contributions to pharmaceutical science through his patents and collaborative efforts have solidified his reputation as a key innovator in the field. His work not only advances scientific understanding but also paves the way for new therapeutic approaches, significantly impacting patient care and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile